A carregar...
Response to trametinib in recurrent low-grade serous ovarian cancer with NRAS mutation: A case report
Low-grade serous ovarian cancer represents a minority of ovarian cancers and has distinctive features from high grade epithelial ovarian cancer. While less aggressive, in advanced stage they can be poorly chemo-responsive and incur a treatment challenge. Next generation sequencing of tumors has allo...
Na minha lista:
| Publicado no: | Gynecol Oncol Rep |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6374783/ https://ncbi.nlm.nih.gov/pubmed/30809568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gore.2019.01.007 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|